Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Takeda Pharma (TKPYY)

Takeda Pharma (TKPYY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,919,552
  • Shares Outstanding, K 1,562,360
  • Annual Sales, $ 15,935 M
  • Annual Income, $ 1,682 M
  • 60-Month Beta 0.42
  • Price/Sales 1.64
  • Price/Cash Flow N/A
  • Price/Book 1.36
Trade TKPYY with:
  • Price/Earnings ttm 12.22
  • Earnings Per Share ttm 1.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/07/19
  • Annual Dividend & Yield 0.58 (3.48%)
  • Most Recent Dividend 0.288 on 09/27/18
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.5000 +7.03%
on 12/18/18
19.2300 -13.73%
on 11/26/18
-2.6300 (-13.68%)
since 11/21/18
3-Month
15.5000 +7.03%
on 12/18/18
21.9399 -24.38%
on 09/26/18
-4.3650 (-20.83%)
since 09/21/18
52-Week
15.5000 +7.03%
on 12/18/18
31.2900 -46.98%
on 02/01/18
-11.8100 (-41.58%)
since 12/21/17

Most Recent Stories

More News
Fujitsu to Initiate On-Site Vaccinations for Employees in Japan

Fujitsu Limited today announced that in accordance with the Japanese government's COVID-19 vaccination policy targeting a June 21, 2021 start for large companies and universities, Fujitsu will initiate...

FJTSY : 35.4100 (+0.71%)
TKPYY : 16.5900 (-0.90%)
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today at the American Transplant Congress (ATC) 2021 Virtual Connect presented results from a new subgroup analysis of SOT recipients...

TKPYY : 16.5900 (-0.90%)
TAK : 16.91 (-0.82%)
Inflammatory Bowel Disease Market Size With CAGR, Scenario, Outlook, Trend and Forecast 2021 - 2030 By ARC

pune, India, Fri, 21 May 2021 00:57:07 / Comserve Inc. / -- Acumen Research and Consulting the global inflammatory bowel disease market is anticipated to reach a market size of around US$ 23,000 Mn by...

ABBV : 114.90 (-0.55%)
NVS : 94.15 (+0.38%)
PFE : 39.48 (+0.46%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG(R) (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML

--- Oral Presentation of the OPTIC Primary Analysis at the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) Annual Meetings

TKPYY : 16.5900 (-0.90%)
TAK : 16.91 (-0.82%)
Mucopolysaccharidosis Treatment Market Size 2021 | Is Predicted to Reach USD 4.37 Billion by 2026, Exhibiting a CAGR of 10.4%

The global mucopolysaccharidosis treatment market size is predicted to reach USD 4.37 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. The growing cases of rare diseases can be critical...

RGNX : 37.89 (-1.07%)
TKPYY : 16.5900 (-0.90%)
Takeda Pharmaceutical Co., Ltd. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 11, 2021 / Takeda Pharmaceutical Co., Ltd. (NYSE:TAK) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on May 11, 2021 at...

TKPYY : 16.5900 (-0.90%)
TAK : 16.91 (-0.82%)
Zika Virus Vaccines Market Size, Share, Trends, Analysis and Forecast 2027

The report on Zika Virus Vaccines provides the clients with a comprehensive analysis of crucial driving factors, consumer behavior, growth trends, product utilization, key player analysis, brand positioning...

CERS : 5.90 (+2.79%)
GSK : 40.57 (-0.22%)
IMV.TO : 2.94 (+1.38%)
INO : 8.82 (+2.92%)
XON : 4.65 (-4.12%)
NLNK : 0.8900 (-12.75%)
TKPYY : 16.5900 (-0.90%)
Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021

Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) ("Takeda") today announced financial results for fiscal year 2020 (period ended March 31, 2021).

TKPYY : 16.5900 (-0.90%)
TAK : 16.91 (-0.82%)
Inflammatory Bowel Disease Treatment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2027

ABT : 111.63 (+1.43%)
ABBV : 114.90 (-0.55%)
NVS : 94.15 (+0.38%)
PFE : 39.48 (+0.46%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Viewpoint Molecular Targeting(TM) Appoints Frank Morich, M.D., Ph.D. to its Board of Directors

- Dr. Morich is an industry leader with over 35 years of experience in biopharmaceuticals with focus in commercialization, R&D and product development -

BAYRY : 15.9650 (-0.59%)
TKPYY : 16.5900 (-0.90%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 17.1900
1st Resistance Point 16.8900
Last Price 16.5900
1st Support Level 16.3200
2nd Support Level 16.0500
3rd Support Level N/A

See More

52-Week High 31.2900
Fibonacci 61.8% 25.2582
Fibonacci 50% 23.3950
Fibonacci 38.2% 21.5318
Last Price 16.5900
52-Week Low 15.5000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar